This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.
Term born or near-term born (> 36w) infants
Birth weight > 2 Kg
History of prenatal opioid exposure
Term born or near-term born (> 36w) infants
APGAR score at 5 min < 7
Any major congenital malformations or genetic syndromes
Need for positive pressure ventilation in the delivery room
APGAR score at 5 min < 7
Indiana University
Lead sponsor
Indiana Clinical and Translational Sciences Institute
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator